Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-01-06
1999-01-19
Kemmerer, Elizabeth C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 24, 530324, 530345, 435 691, 435 692, C07K 1481, A61K 3855, A61K 3857
Patent
active
058613773
ABSTRACT:
The present invention relates to novel inhibitors belonging to the family of antistasin-type serine proteinase inhibitors, to their isolation from the medical leech Hirudo medicinalis, to DNA sequences encoding the novel inhibitors, to variants obtained by recombinant DNA technology or peptide synthesis, pharmaceutical compositions containing the inhibitors, and to their use in diagnosis and therapy.
REFERENCES:
patent: 4588587 (1986-05-01), Gasic
patent: 4668662 (1987-05-01), Tripier
patent: 4835253 (1989-05-01), Burton
Condra et al. Isolation and structural characterization of a potent inhibitor of coagulation Factor Xa from the leech Haementeria ghilianii. Thrombosis and Haemostasis. vol. 61, No. 3, pp. 437-441, 1989.
Nutt et al. Purification and characterization of recombinant antistasin: a leech-derived inhibitor of coagulation Factor Xa. Archives of Biochemistry and Biophysics. vol. 285, No. 1, pp. 37-44, Feb. 15, 1991.
Holt et al. Antistasin, and inhibitor of coagulation and metastasis, binds to sulfatide (Gal(3-SO.sub.4).beta.1-1Cer) and has a sequence homology with other proteins that bind sulfated glycoconjugates. The Journal of Biological Chemistry. vol.264, No. 21, pp. 12138-12140, 1989.
Hofmann et al. Site-directed mutagenesis of the leech-derived Factor Xa inhibitor antistasin. Biochemical Journal. vol.287, pp. 943-949, 1992.
Blankenship et al. Amino acid sequence of ghilanten: anticoagulant-antimetastatic principle of the South American leech, haementeria ghilianii. Biochemical and Biophysical Research Communications. vol. 166, No. 3, pp. 1384-1389, Feb. 14, 1990.
Sollner, C., et al., "Isolation and characterization of hirustasin, an antistasin-type serine-proteinase inhibitor from the medical leech Hirudo medicinalis", Europ. J. Biochem., 219:937-943 (1994).
Achstetter T. and Wolf D. H., "Proteinases, Proteolysis and Biological Control in the Yeast Saccharomyces cerevisiae", Yeast, 1:139-157 (1985).
Ako, H., et al., The Preparation of Anhydro-trypsin and Its Reactivity with Naturally Occurring Proteinase Inhibitors:, Biochem. Biophys. Res. Com., 47(6):1402-1407 (1972).
Baskova, I.P., et al., Abstract 74160, "Inhibition of Human Blood Plasma Kallikrein by Salivary Gland Secretion and Extracts of the Medicinal Leech", Biological Abstracts, 87(7):AB795 (1989).
Bieth, J.G., "Pathophysiological Interpretation of Kinetic Constants of Protease Inhibitors", Europ. Physopat. Resp., 16:183-195 (1980).
Chase, T. Jr., et al., "Titration of Trypsin, Plasmin, and Thrombin with p-Nitrophenyl p'-Guanidinobenzoate HC1", Methods Enzymol., XIX:20-27 (1970).
Dunwiddie, C., et al., "Antistasin, a Leech-deriuved Inhibitor of Factor Xa--Kinetic Analysis of Enzyme Inhibition and Identification of the Reactive Site", J. Biol. Chem., 264(28) 16694-16699 (1989).
Friedman, M., et al., "The Chromatographic Determination of Cystine and Cysteine Residues in Proteins as S-.beta.-(4-Pyridylethyl) cysteine", J. Biol. Chem., 245(18):3868-3871 (1970).
Furst, P., et al., "Cooper Activates Metallothionein Gene Transcription by Altering the Conformation of a Specific DNA Binding Protein", Cell, 55:705-717 (1988).
Han, J.H., et al., "Cloning and Expression of cDNA Encoding Antistasin, A Leech-derived Protein Having Anti-coagulant and Anti-metastatic Properties", Gene, 75:47-57 (1989).
Hinnen, A., et al., "Transformation of Yeast", PNAS, 73(4):1929-1933 (1978).
Holstein, T.W., et al., The Primitive Metazoan Hydra Expresses Antistasin, A Serine Protease Inhibitor of Vertebrate Blood Coagulation: cDNA Cloning, Cellular Localisation and Developmental Regulation:, FEBS Letters, 309(3):288-292 (1992).
Morrison, J.F., "Kinetics of the Reversible Inhibition of Enzyme-catalysed Reactions by Tight-Binding Inhibitors", Biochim. Biophys. Acta, 185:269-286 (1969).
Nutt, Elka, et al., "The Amino Acid Sequence of Antistasin--A Potent Inhibitor of Factor Xa Reveals a Repeated Internal Structure", J. Biol. Chem., 263(21):10162-10167 (1988).
Harvey, R.P., et al., "Cloning and Expression of a cDNA coding for the anticoagulant Hirudin from the Bloodsucking Leech, Hirudo medicinalis", PNAS, 83(2):1084-1088 (1986).
Rudolph, H., et al., "One-step Gene Replacement in Yeast by Cotransformation", Gene, 36:87-95 (1985).
Smith, P.K., et al., "Measurement of Protein Using Bicinchoninic Acid", Analytical Biochemistry, 150:76-85 (1985).
Tuszynski, G.P., et al., Isolation and Characterization of Antistasin--An Inhibitor of Metastasis and Coagulation:, J. Biol. Chem., 262(20):9718-9723 (1987).
Vlasuk, G.P., et al., Comparison of the In Vivo Anticoagulant Properties of Standard Heparin and the Highly Selective Factor Xa Inhibitors Antistasin and Tick Anticoagulant Peptide (TAP) in a Rabbit Model of Venous Thrombosis:, Thrombosis Haemostasis, 65:257-262 (1991).
Zhou, G.X., Kallistatin: A Novel Human Tissue Kallikrein Inhibitor, J. Biol. Chem., 267(36):25873-25880 (1992).
Zoller, M.J., et al., Oligonucleotide-Directed Mutagenesis of DNA Fragments Cloned into M13 Vectors:, Methods in Enzymology, vol. 100, Part B., Chapter 32:468-500, published by Academic Press (1983).
Fritz Hans
Heim Jutta
Sommerhoff Christian
Kemmerer Elizabeth C.
Lathrop Brian
McCormack Myra H.
Novartis AG
LandOfFree
Antistasin type serine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antistasin type serine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antistasin type serine protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1246697